Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
RGD-deleted FMDV protects cattle from challenge; leaves open whether receptor-binding mutants can be developed into commercial vaccines.
Binding of foot-and-mouth disease virus (FMDV) to cells requires an arginine-glycine-aspartic acid (RGD) sequence in the capsid protein VP1. We have genetically engineered an FMDV in which these three amino acids have been deleted, producing a virus particle which is unable to bind to cells. Cattle vaccinated with these receptor binding site-deleted virions were protected from disease when challenged with a virulent virus, demonstrating that these RGD-deleted viruses could serve as the basis for foot-and-mouth disease vaccines safer than those currently in use. This strategy may prove useful in the development of vaccines for other viral diseases.
No takes yet. Share an insight, caveat, or question.
McKenna et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: